Rui Shi
- Co-authors
- Hongbo WangSitian WeiJun ZhangZhicheng YuHua TengXiaoyan XinDilu FengHuaming Tan
- Topics
- Ferroptosis and cancer prognosis (8 papers)Cancer-related molecular mechanisms research (7 papers)Endometrial and Cervical Cancer Treatments (6 papers)
- Partner nations
- ChinaUnited KingdomBelarus
In The Last Decade
Rui Shi
38 papers receiving 676 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 350
- Cancer Research 201
- Immunology 127
- Pulmonary and Respiratory Medicine 105
- Oncology 88
Countries citing papers authored by Rui Shi
This map shows the geographic impact of Rui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Shi more than expected).
Fields of papers citing papers by Rui Shi
This network shows the impact of papers produced by Rui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Shi. The network helps show where Rui Shi may publish in the future.
Co-authorship network of co-authors of Rui Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Rui Shi. A scholar is included among the top collaborators of Rui Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Shi. Rui Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinomabreakdown → | 63 |
| 7 | 20 | |
| 8 | 6 | |
| 9 | 7 | |
| 10 | 30 | |
| 11 | 5 | |
| 12 | 18 | |
| 13 | 5 | |
| 14 | 53 | |
| 15 | 27 | |
| 16 | 11 | |
| 17 | 3 | |
| 18 | 10 | |
| 19 | 3 | |
| 20 | 96 |
About Rui Shi
Rui Shi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 40 papers that have together received 682 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (7 papers) and Endometrial and Cervical Cancer Treatments (6 papers). The work is most often cited by research in Cancer Research (201 citations), Obstetrics and Gynecology (83 citations) and Reproductive Medicine (87 citations). Rui Shi has collaborated with scholars based in China, United Kingdom and Belarus. Frequent co-authors include Hongbo Wang, Sitian Wei, Jun Zhang, Zhicheng Yu, Hua Teng, Xiaoyan Xin, Dilu Feng, Huaming Tan, Min Li and Shuqi Chi. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.